Novartis AG | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (100)

Latest Posts

About This Stock More About This Stock
Pharma Stock Roundup: Merck, Sanofi, AstraZeneca, Novartis' Q1 Results, Pipeline & Regulatory Updates
Article By: Zacks Investment Research
Sunday, April 28, 2024 4:00 PM EDT
The first-quarter 2024 earnings season picked up pace this week, with Merck, Sanofi, Novartis, and AstraZeneca announcing their first-quarter results. Three of the four companies beat estimates for both earnings and sales in the first quarter.
In this article: AZN, JNJ, MRK, NVS, SNY
Top Analyst Reports For Novartis, American Express & ConocoPhillips
Article By: Sheraz Mian
Monday, April 22, 2024 7:25 PM EDT
Today's Research Daily features new research reports on 16 major stocks, including Novartis AG (NVS), American Express Company (AXP) and ConocoPhillips (COP).
In this article: AXP, COP, NVS Also: ETN, SLB, NFLX
Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week
Article By: ChinaBio® Today
Saturday, January 13, 2024 1:20 PM EDT
Shanghai Argo Biopharma entered 2 agreements with Novartis, out-licensing four next-gen RNAi therapeutics for $185 million upfront and a total value of $4.2 billion. Additionally, Ambrx Biopharma will be acquired by Johnson & Johnson for $2 billion.
In this article: GSK, JNJ, NVS, BAYRY, BNTX, PRAX, AMAM, HLVX Also: TAK
Bullish Continuation In '24? 3 Market Areas To Watch
Article By: Zacks Investment Research
Wednesday, January 10, 2024 11:00 PM EDT
This article discusses 3 market areas that should outperform dramatically over the next 12 months...
Week In Review: 2024 Kicks Off With Three Deals Worth A Total Of $4 Billion
Article By: ChinaBio® Today
Sunday, January 7, 2024 7:20 AM EDT
Suzhou Ribo Life Science formed a collaboration with Boehringer Ingelheim in a deal that could be worth up to $2 billion. Additionally, Allorion Therapeutics has out-licensed global rights (ex-China) for AVZO-021 to Avenzo Therapeutics.
In this article: NVS, RHHBY, TSVT Also: BNTX, APLM

Latest Tweets for $NVS

No tweets yet!



Daily Stock Pick: Novartis
Bill Myers 10/4/2019 3:12:59 PM

I like $NVS.

OncoSec Raising Its Profile In Fight Against Cancer
BreakingBad News 9/6/2017 3:48:05 PM

More good news on the war against #Cancer, thanks. #Novartis also has made great progress against B-cell acute lymphoblastic leukemia: $ONCS $NVS

Finally… A Cure for Cancer?
BreakingBad News 9/6/2017 3:30:54 PM

Lot of good news against the war on #Cancer. Also just read this about #OncoSec: $ONCS $NVS

Novartis Receives FDA Approval For An Acute Myeloid Leukemia Drug
Terry Chrisomalis 5/1/2017 12:22:24 AM

Yes it does indeed. #Novartis has been doing very well lately. $NVS

Novartis Receives FDA Approval For An Acute Myeloid Leukemia Drug
Danielle Rogers 4/30/2017 5:29:49 PM

Triple the effectiveness over a placebo looks very promising! $NVS

1 to 6 of 6 comments